Tuukka Tammi Drug User Organisations in the Nordic Countries What Do They Want?

Similar documents
Introduction. Anker, Jørgen; Asmussen, Vibeke; Kouvonen, Petra; Tops, Dolf. Published in: Drug users and spaces for legitimate action

Statement by the Portuguese Deputy Minister for Health. Vienna, 8 March 2010

Swedish drug policy a balanced policy based on health and human rights

Drug Consumption Rooms Worldwide

Drug Use, Harm Reduction, and HIP

Overall aim Improving the access to and the quality of health and social services for marginalised people

1. RE-COMMISSIONING OF DRUG AND ALCOHOL TREATMENT AND RECOVERY SERVICES

Understanding the Opiate Epidemic

Active drug users - struggling for rights and recognition. Anker, Jørgen. Publication date: 2006

Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre

Partnership between the government, municipalities, NGOs and the industry: A new National Alcohol Programme in Finland

Needle exchange programs

The Pillars Approach: A Case Study

Patient First. Aneurin Bevan University Health Board. Personal Responsibility. Values and Behaviours Framework. Passion for Improvement

Identifying Common Ground on Public Health for UNGASS 2016:

Groups of young people in Uganda that need to be targeted with HIV interventions

A comprehensive strategy for alcohol, narcotics, doping and tobacco policy, Ministry of Health and Social Affairs

HIV epidemic around the Baltic Sea

HIV AND PEOPLE WHO INJECT DRUGS

Peer workers and Service innovation. Experiences from Norway, Sweden and Canada. Karl-Johan Johansen and Dag Øivind Antonsen

Very interesting is what recovered users are saying about harm reduction:

QuADS Organisational Standards and Professional Competencies in needle exchange

Eurasian Harm Reduction Association (EHRA) Strategic Framework

Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, Anand Grover

COUNTRY TABLE. MONTENEGRO.

The impact of economic recession on drug users and drug treatment

Agenda. Follow up from the meeting in London

Harm Reduction in Nigeria

Eurasian Harm Reduction Association (EHRA) Strategic Framework

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen

Harm Reduction: Blending Principles and Practice

A SAFE AND DIGNIFIED LIFE WITH DEMENTIA

CABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND

Rapporteur report of Session 2: New Trends in TDI clients. Thursday, September 20th 2012, ( Room 106) Chair: Dragica Katalinic

Harm reduction among drug users in Spain

Mental Health Strategy. Easy Read

HIV testing in Europe: From policy to effectiveness

INTRAVENOUS INJECTING DRUG USE.

IMPLEMENTING HOUSING FIRST. Practical Strategies and Tools for Service Providers

Substance use and misuse

Technical Guidance Note for Global Fund HIV Proposals

Drug Policy and the HIV Movement. SAULIUS CAPLINSKAS MD, PhD

provides services for drug and alcohol users, families and carers.

Occupational therapy the future. Strategic agenda

Part One of a Two Part Series: Harm Reduction and Substance Use- What You Need To Know

Table Of Content. Outputs... 8

Hepatitis prevention in the context of HIV prevention point work in Latvia

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

ESTABLISHMENT OF SUPERVISED INJECTING FACILITY IN VICTORIA SUBMITTED BY THE SALVATION ARMY

Part 1: Introduction & Overview

Develop an awareness of substance misuse

IDU Outreach Project. Program Guidelines

Hearing Loss: The Statistics

Practical Harm Reduction Strategies. NAEH Annual Conference July 2015

NORDIC HEALTH RESEARCH AND INNOVATION NETWORKS

The International Network of People who Use Drugs (INPUD) is currently expanding its membership of drug user activists around the globe.

Gender Treatment Recovery Future Challenges

Interview with Ragnhildur Helgadóttir, Reykjavik, 23d February 2009

Prevention Point Philadelphia

Decriminalization of Personal Use of Psychoactive Substances

EG on Prison Health Third Meeting Paris France June 2007

Developing a Public Education Campaign on Prescription Opiates. Samantha Kaan, MPH Multnomah County Health Department April 24, 2015

Executive Summary. No Fire, No Smoke: The Global State of Tobacco Harm Reduction 2018

Key Ministry & Government Initiatives

Syringe Service Programs: Platforms for Engagement. September 28, 2018 Melissa Green, MASW, LSW Harm Reduction Program Manager Columbus Public Health

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

Gilberto Gerra. Drug Prevention and Health Branch

How system-based treatment monitoring can inform decision makers a Nordic view. Kerstin Stenius

Objectives Measurable Indicators Means of Verification Important Assumptions Goal To promote an inclusive society where

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Drug Misuse Research Division

What is harm reduction?

Decriminalization of Personal Use of Psychoactive Substances

THE GLOBAL HEALTH SECURITY AGENDA. We have to change our mindsets and start thinking about biological threats as the security threats that they are.

The forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre

Shane Butler School of Social Work & Social Policy Trinity College Dublin

Advocating for Syringe Exchange Programs

Donne e addiction: La prospettiva di genere nella medicina delle dipendenze AULSS 9 Treviso 7 ottobre 2016

ALCOHOL AND DRUGS PLANNING FRAMEWORK

European Legal Database on Drugs

Prevention of and Immunisation against Hepatitis B and C

IMPLEMENTING THE WHO GLOBAL DEMENTIA ACTION PLAN. Glenn Rees, Chair Alzheimer s Disease International (ADI)

Peliklinikka Gambling Clinic

International Meeting 1. Bremen, Germany 10 & 11/02/17. Intellectual Outputs

DRUGSCOPE MANIFESTO European Parliament Elections 2004: Next steps for European drug policy

Insights into shared and specific features of intensive drug use in Europe

Recovery Community Organizations SOCIAL MEDIA TOOL KIT

Click for Support REALized

European Parliament Symposium

Moving Beyond the War on Drugs

ETHICS COMMITTEES. Mariela Mautone Sindicato Médico del Uruguay

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success

Drug problems in Dublin

JSNA Substance Misuse

Achieve. Salford Young People s Service. Salford Recovery

Appearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse

The science of the mind: investigating mental health Treating addiction

NEA-PROJECT. Securing Housing for Women

Ending HIV/AIDS Among Injection Drug Users in Minnesota

Feasibility study on drug consumption rooms in Belgium (DRUGROOM) Summary

Transcription:

Tuukka Tammi Drug User Organisations in the Nordic Countries What Do They Want?

Drug User Organisations in the Nordic Countries What Do They Want? Tuukka Tammi tutkimuspäällikkö/research Manager A-klinikkasäätiö/A-Clinic Foundation tuukka.tammi@a-klinikka.fi

Further reading: Asmussen Frank, V., Anker, J.& Tammi, T. (2011). Drug user organizations in the Nordic countries local, national and international dimensions. Forthcoming in Substance Use and Misuse Journal. Anker, J., Asmussen, V., Kouvonen, P., Tops, D. (eds.) (2006). Drug users and spaces for legitimate action. Helsinki: NAD Publications. Tammi, T. (2006). Who is the expert? The patient groups and the Finnish substitution treatment policy. In: Asmussen, Vibeke, Jørgen Anker, Dolf Tops & Petra Kouvonen (eds.) Drug Users and Spaces for Legitimate Action. Helsinki: NAD publications Nr 49.

Starting points: Before - and largely still so - Drug Users have been regarded only as targets for control, prevention and treatment i.e. not regarded as competent partners in decision-making or service design. What are reasons for that? Drug user is not capable (addiction as a disease of the will?)?; or he/she should not have rights for that (->moralistic views drug user as a wrong-doer/criminal?)?; some other reason? At the same time almost every other chronic disease category (different cancers, diabetics, celiacic disease, skin diseases, mental health patients, etc. etc.) has their own patient interest groups, and they are increasingly powerful. Drug addiction also classified as a disease

What do we mean by Drug User Organisations (DUOs)? Organisations that represent and advocate for active hard drug users, mainly opiates, but also other drug users. The first drug users interest organizations came into being in the late 1970s in Holland, called Junkiebonds. In other European countries, drug user associations evolved in the mid-1980s when AIDS became a major concern, due to the fear of an epidemic among injecting drug users. Today drug user organizations are present in over 40 countries around the world. In the Nordic countries, drug user organizations emerged from the beginning of the 1990s (in DK). International networks of drug users strengthened since 2005.

Who are the drug user organisations (DUOs) in Denmark, Finland, Norway and Sweden? What kind of political agendas they have in four different, but also in many ways similar countries; the Nordic welfare states. DUOs in in Nordic countries: The Swedish Drug User Union (SDUU) Suomen Lumme ry in Finland The Danish Drug User Union (DDUU) FHN, RIO, LARnett n Norway

SDUU http://www.svenskabrukarforeningen.se/om

Suomen Lumme ry Established at the end of 2005. About 80 members, of which half are active drug users. The core group consists of clients and peer educators of the needle exchange programme in Helsinki. The goals and activities of SL are somewhat similar to its Nordic sister organizations in Denmark and Sweden In general, the main goals of SL are to gain more respect and better treatment of drug users in both public services and elsewhere in society. SL aims to give voice to users; to show that drug users are also responsible citizens; to advocate specific harm reducing measures; and to provide fellow drug users with support and advice. SL is closely connected to the Needle Exchange Programme (NEP) in Helsinki.

In Norway the field is more fragmented: FHN (Association for Human Drug Policy): For both active drug users and others that lobby for general drug political changes in Norway, moving away from a repressive policy towards a more human as they call it drug policy. RIO: Ex-drug users organization. LARnett: A patient group, mainly run/entirely run by patients in substitution treatment.

Typically DUOs advocate harm reduction measures (health care and health skills and information, especially in relation to infectious diseases and overdosing); but also promote drug users rights and position in society; support that drug users have easy access to drug treatment; seek to decriminalize or de-penalize drug use and possession of drugs for own use and to lower the penalties for drug-related crimes. function as a place to meet and socialize with other drug users. Some of them have drop-in facilities and organize different forms of activities for their members.

What Do They Want? One can say that drug user organizations have a double purpose: 1) they have a political aspect where they try to influence drug policies; to represent the interests of drug users in national or local political arenas; and to spread information about drugs, the risks of drug use, etc. 2) they have a social aspect where they provide self-help and support to drug users; provide social networks for drug users; create identity and recognition for drug users; and establish a free space, without stigmatization and control. Our review of DUOs show that drug users are both willing and able to step out from their externally given role as only passive targets, to the direction of serious and organised actors in decision-making and service design about them. So: Nothing about them without them?

Opportunities & challenges for DUOs 1. The role of drug policy approach: (public) health/harm reduction orientation opens up space for DUOs, whereas in abstinenceoriented prohibition only ex-users are regarded as legitimate actors. 2. The role of welfare services: clients and patients as lay experts and partners in service design. Also funding opportunities available. 3. Vulnerability: small core groups/individuals, often city-based, danger of being co-opted by public services and to loose autonomy? 4. The importance of international networks: INPUD, ENCOD, IHRA, NAMA, CORRELATION.